Your browser doesn't support javascript.
loading
Statistical Considerations in the Design of Clinical Trials Targeting Prodromal Parkinson Disease.
Macklin, Eric A; Coffey, Christopher S; Brumm, Michael C; Seibyl, John Peter.
Afiliação
  • Macklin EA; From the Biostatistics Center (E.A.M.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Biostatistics (C.S.C., M.C.B.), College of Public Health, University of Iowa, Iowa City; and Institute for Neurodegenerative Disorders (J.P.S.), New Haven, CT. emacklin@mgh.harvar
  • Coffey CS; From the Biostatistics Center (E.A.M.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Biostatistics (C.S.C., M.C.B.), College of Public Health, University of Iowa, Iowa City; and Institute for Neurodegenerative Disorders (J.P.S.), New Haven, CT.
  • Brumm MC; From the Biostatistics Center (E.A.M.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Biostatistics (C.S.C., M.C.B.), College of Public Health, University of Iowa, Iowa City; and Institute for Neurodegenerative Disorders (J.P.S.), New Haven, CT.
  • Seibyl JP; From the Biostatistics Center (E.A.M.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Biostatistics (C.S.C., M.C.B.), College of Public Health, University of Iowa, Iowa City; and Institute for Neurodegenerative Disorders (J.P.S.), New Haven, CT.
Neurology ; 99(7 Suppl 1): 68-75, 2022 08 16.
Article em En | MEDLINE | ID: mdl-35970588

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article